To determine the potential contribution of T lymphocytes in inhibiting tumor growth, we analyzed the efficacy of low-dose TSA in tumor-bearing recombination activating gene 2 (RAG2) knock out (KO) mice. Here, RAG2 is linked to neoplasm.